Ferroportin-inhibitor salts

US11129820B2 · kind B2 · utility

Assignee

• Vifor (International) AG · CH

Inventors

• Collin D. Morris · Grayslake, US
• Fritz Blatter · Reinach, CH
• Giuseppe Lapadula · Basel, CH
• Stefan Reim · Sankt Gallen, CH
• Michael Burgert · Friedrichshafen, DE
• Erik Philipp · Arbon, CH

Key dates

• Filing date: Apr 18, 2018
• Grant date: Sep 28, 2021
• Expiry date: Apr 18, 2038

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D417/14
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The invention relates to novel salts of compounds of the general formula (I), pharmaceutical compositions comprising them and the use thereof as medicaments, in particular for the use as ferroportin inhibitors, more particularly for the use in the prophylaxis and/or treatment of diseases caused by a lack of hepcidin or iron metabolism disorders, such as particularly iron overload states such as in particular thalassemia, sickle cell disease and hemochromatosis.